Meyer-Wentrup F - Search Results

1

B-cell receptor signaling in lymphoid malignancies and autoimmunity.

Avalos AM, Meyer-Wentrup F, Ploegh HL. Avalos AM, et al. Adv Immunol. 2014;123:1-49. doi: 10.1016/B978-0-12-800266-7.00004-2. Adv Immunol. 2014. PMID: 24840946 Review.

2

Monovalent engagement of the BCR activates ovalbumin-specific transnuclear B cells.

Avalos AM, Bilate AM, Witte MD, Tai AK, He J, Frushicheva MP, Thill PD, Meyer-Wentrup F, Theile CS, Chakraborty AK, Zhuang X, Ploegh HL. Avalos AM, et al. J Exp Med. 2014 Feb 10;211(2):365-79. doi: 10.1084/jem.20131603. Epub 2014 Feb 3. J Exp Med. 2014. PMID: 24493799 Free PMC article.

3

Increased risk of hematologic malignancies in primary immunodeficiency disorders: opportunities for immunotherapy.

Verhoeven D, Stoppelenburg AJ, Meyer-Wentrup F, Boes M. Verhoeven D, et al. Clin Immunol. 2018 May;190:22-31. doi: 10.1016/j.clim.2018.02.007. Epub 2018 Feb 27. Clin Immunol. 2018. PMID: 29499421 Free article. Review.

4

New targets for antibody therapy of pediatric B cell lymphomas.

van Vuren A, Meyer-Wentrup F. van Vuren A, et al. Pediatr Blood Cancer. 2014 Dec;61(12):2158-63. doi: 10.1002/pbc.25193. Epub 2014 Aug 23. Pediatr Blood Cancer. 2014. PMID: 25154500 Review.

5

The role of programmed cell death-1 (PD-1) and its ligands in pediatric cancer.

van Dam LS, de Zwart VM, Meyer-Wentrup FA. van Dam LS, et al. Pediatr Blood Cancer. 2015 Feb;62(2):190-197. doi: 10.1002/pbc.25284. Epub 2014 Oct 18. Pediatr Blood Cancer. 2015. PMID: 25327979 Review.

6

Antibody therapy of pediatric B-cell lymphoma.

Meyer-Wentrup F, de Zwart V, Bierings M. Meyer-Wentrup F, et al. Front Oncol. 2013 Apr 2;3:68. doi: 10.3389/fonc.2013.00068. eCollection 2013. Front Oncol. 2013. PMID: 23565504 Free PMC article.

7

Upcoming immunotherapeutic combinations for B-cell lymphoma.

Greve P, Meyer-Wentrup FAG, Peperzak V, Boes M. Greve P, et al. Immunother Adv. 2021 Feb 9;1(1):ltab001. doi: 10.1093/immadv/ltab001. eCollection 2021 Jan. Immunother Adv. 2021. PMID: 35919738 Free PMC article. Review.

8

TLR3 triggering regulates PD-L1 (CD274) expression in human neuroblastoma cells.

Boes M, Meyer-Wentrup F. Boes M, et al. Cancer Lett. 2015 May 28;361(1):49-56. doi: 10.1016/j.canlet.2015.02.027. Epub 2015 Feb 16. Cancer Lett. 2015. PMID: 25697485

9

The inhibitory Fc gamma IIb receptor dampens TLR4-mediated immune responses and is selectively up-regulated on dendritic cells from rheumatoid arthritis patients with quiescent disease.

Wenink MH, Santegoets KC, Roelofs MF, Huijbens R, Koenen HJ, van Beek R, Joosten I, Meyer-Wentrup F, Mathsson L, Ronnelid J, Adema GJ, Bonvini E, Koenig S, van den Berg WB, van Riel PL, Radstake TR. Wenink MH, et al. J Immunol. 2009 Oct 1;183(7):4509-20. doi: 10.4049/jimmunol.0900153. Epub 2009 Sep 4. J Immunol. 2009. PMID: 19734236

10

Antibody therapies for lymphoma in children.

de Zwart V, Gouw SC, Meyer-Wentrup FA. de Zwart V, et al. Cochrane Database Syst Rev. 2016 Jan 19;2016(1):CD011181. doi: 10.1002/14651858.CD011181.pub2. Cochrane Database Syst Rev. 2016. PMID: 26784573 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page